Increased IFN-γ production by GPC3-specific CD4 + T cells and enhanced activation and amplification of GPC3-specific CTLs in vitro and in vivo, resulting in CTLs-dependent effective killing of GPC3-expressing HCC cells [599]. The gene discussed is IFNG; the disease is hepatocellular carcinoma.